Valuation : Treace Medical Concepts, Inc.

Market Cap 313M 269M 253M 231M 432M 29.58B 433M 3B 1.16B 15.15B 1.17B 1.15B 48.26B P/E 2026 *
-5.65x
P/E 2027 * -6.21x
Enterprise Value 358M 308M 290M 265M 495M 33.9B 497M 3.44B 1.33B 17.36B 1.35B 1.32B 55.3B EV / Sales 2026 *
1.73x
EV / Sales 2027 * 1.8x
Free-Float
74.43%
Yield 2026 *
-
Yield 2027 * -
1 day-1.43%
1 week+2.34%
Current month+2.34%
1 month+1.05%
3 months+37.04%
6 months+236.36%
Current year+96.33%
1 week 4.57
Extreme 4.57
4.93
1 month 4.25
Extreme 4.25
5.01
Current year 1.17
Extreme 1.17
5.2
1 year 1.17
Extreme 1.17
7.63
3 years 1.17
Extreme 1.17
15.98
5 years 1.17
Extreme 1.17
31.02
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 01/07/2013
Director of Finance/CFO 56 01/09/2020
Chief Tech/Sci/R&D Officer - 01/03/2022
Director TitleAgeSince
Chairman 54 20/05/2025
Director/Board Member 65 20/11/2020
Director/Board Member 68 20/11/2020
Date Insider Type Main position Quantity % Market Cap. Importance
8/24/26 A Buy

Chief Executive Officer

11,000 0.0170%
8/9/26 A Tax

Chief Financial Officer

-37,102 0.0572%
8/9/26 A Tax

Responsable ventes & marketing

-9,814 0.0151%
Change 5-day change 1-year change 3-year change Capi.($)
-1.43%+2.34%-32.91%-66.25% 313M
+0.32%-0.29%+14.46%+11.27% 12.69B
-0.21%0.00%+14.39%+30.86% 6.92B
-2.33%+14.93% - - 6.54B
-3.19%-12.75%+22.39%+12.67% 5.89B
-3.40%-0.93%-21.51%+49.41% 5.04B
-0.93%-1.66%-30.95%-21.24% 3.79B
+1.70%+1.64%+46.09%-10.30% 2.09B
+1.05%-4.94%-5.41%+120.65% 1.69B
-2.09%-4.39%+45.93%-18.01% 1.65B
Average -1.05%+0.03%+5.83%+12.12% 4.66B
Weighted average by Cap. -1.09%+0.46%+8.53%+18.25%

Financials

2026 *2027 *
Net sales 207M 178M 168M 153M 287M 19.62B 287M 1.99B 769M 10.05B 779M 762M 32.01B 222M 191M 179M 164M 306M 20.97B 307M 2.13B 822M 10.74B 833M 814M 34.21B
Net income -55.26M -47.53M -44.7M -40.81M -76.32M -5.23B -76.56M -530M -205M -2.68B -208M -203M -8.53B -51.01M -43.87M -41.26M -37.67M -70.44M -4.82B -70.67M -489M -189M -2.47B -192M -187M -7.87B
Net Debt 45.67M 39.27M 36.94M 33.72M 63.06M 4.32B 63.27M 438M 169M 2.21B 171M 168M 7.04B 86.44M 74.34M 69.92M 63.82M 119M 8.17B 120M 829M 320M 4.19B 325M 318M 13.33B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
04/09/26 $4.810 -1.43% 231,834
03/09/26 $4.880 +3.83% 275,358
02/09/26 $4.700 +2.17% 172,390
01/09/26 $4.600 -2.13% 254,456
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.810USD
Average target price
5.500USD
Spread / Average Target
+14.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!